Elsevier

Biomaterials

Volume 33, Issue 18, June 2012, Pages 4618-4627
Biomaterials

Core–shell Fe3O4@NaLuF4:Yb,Er/Tm nanostructure for MRI, CT and upconversion luminescence tri-modality imaging

https://doi.org/10.1016/j.biomaterials.2012.03.007Get rights and content

Abstract

Core–shell Fe3O4@NaLuF4:Yb,Er/Tm nanostructure (MUCNP) with multifunctional properties has been developed using a step-wise synthetic method. The successful fabrication of MUCNP has been confirmed by transmission electron microscopy, powder X-ray diffraction, energy-dispersive X-ray analysis and X-ray photoelectron spectroscopy. The MUCNP exhibits superparamagnetic property with saturation magnetization of 15 emu g−1, and T2-enhanced magnetic resonance (MR) effect with an r2 value of 21.63 s−1 mM−1 at 0.5 T, resulting from the Fe3O4 cores. Moreover, the NaLuF4-based MUCNP provides excellent X-ray attenuation and upconversion luminescence (UCL) emission under excitation at 980 nm. In vivo MR, computed tomography (CT) and UCL images of tumor-bearing mice show that the MUCNP can be successfully used in multimodal imaging. In vitro tests reveal that the MUCNP is non-cytotoxic. These results suggest that the developed MUCNP could be served as an MR, CT and UCL probe for tri-modality imaging.

Introduction

Recent years have witnessed the rapid pace of research and development of rare earth upconversion nanophosphors (RE-UCNPs) as potential bioimaging agents because of their distinct optical and chemical properties, such as sharp emission lines, long lifetimes, superior photostability and non-photoblinking [1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33]. The upconversion luminescence (UCL) process involves the conversion of low-energy light in the near-infrared (NIR) region to higher energy visible light through multiple photon absorption or energy transfer [1], [2], [3], [4], [5], [6], [7], [8]. This special photoluminescence mechanism excludes both conventional luminescent materials (such as QDs and organic dyes) and endogenous fluorescent substances. As a result, RE-UCNPs for photoluminescence bioimaging exhibit many advantages, such as the use of non-invasive NIR radiation and the absence of autofluorescence of biological tissues [11], [12]. In particular, Yb3+ and Tm3+ co-doped RE-UCNPs show intense UCL emission at 800 nm under continuous-wave excitation at 980 nm, and are therefore ideal candidates for high contrast whole-body small-animal imaging [10], [12], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28]. For example, we have recently reported that the detection limit for the UCL imaging of a whole-body mouse is only 50 cells [28].

Usually, photoluminescent imaging has one shortcoming of the low penetration depth of the excitation and emission light, which can be solved by magnetic resonance imaging (MRI) [34], [35] and X-ray computed tomography (CT). To combine the merits of these imaging modalities, multimodal imaging based on RE-UCNPs has been developed. For example, by introducing Gd3+ in the host matrix or on the nanoparticle surface, magnetic-luminescent RE-UCNPs have successfully been fabricated for dual-modal imaging of T1-enhanced MRI and UCL imaging [36], [37], [38], [39]. CT gives high spatial resolution and 3D tomography information about deep anatomic structures due to the high penetration of X-rays, whilst MRI provides comparable resolution but with far better contrast. Considering the different spatial resolution, imaging penetration depth, and areas of application of these different imaging modalities, a combination of CT, MRI and luminescence imaging using a sole probe is urgently required.

Owing to their large magnetic moment, superparamagnetic Fe3O4 nanoparticles have been combined with RE-UCNPs together for fabricating magnetic operation, T2-enhanced MR imaging and UCL imaging [40]. For example, Liu et al. developed multifunctional nanoparticles, NaYF4:Yb,Er@Fe3O4@Au, which combined optical and magnetic properties useful for multimodality imaging [41]. Recently, our group reported an imaging agent with NaYF4:Yb,Tm@FexOy core–shell nanostructure for T2 MRI and UCL bimodal lymphatic imaging [42]. It should be noted that the intensity of UCL emission will be weaker in the presence of the Fe3O4-shielding, because both excitation and emission light are absorbed by the Fe3O4 shell. Therefore, it is expected that a different core–shell nanostructure with Fe3O4 nanoparticles as core and RE-UCNPs as shell might show excellent upconversion luminescent and magnetic properties.

NaLuF4 may be an ideal building block for multimodal bioimaging probes since RE-UCNPs based on the NaLuF4 host have high UCL quantum yield [10], [28]. Furthermore, owing to the large atomic number and high X-ray absorption coefficient of lutetium, NaLuF4 can be used as a contrast agent for CT imaging. In this work, core–shell Fe3O4@NaLuF4:Yb,Er/Tm nanostructure (MUCNP) with Fe3O4 as the core and NaLuF4:Yb,Er/Tm as the shell layer has been designed and synthesized by a step-wise method. The core–shell structure was characterized by transmission electron microscopy (TEM), powder X-ray diffraction (XRD), energy-dispersive X-ray (EDX) analysis and X-ray photoelectron spectroscopy (XPS). The upconversion luminescent, magnetic and X-ray attenuation properties of these nanoparticles were investigated in detail. Moreover, we have also investigated the multimodal performance for MR, CT and UCL imaging following an intratumoral injection of MUCNP. Finally, the cytotoxicity of the MUCNP is described.

Section snippets

Materials

Rare earth oxides Lu2O3 (99.999%), Yb2O3 (99.999%), Er2O3 (99.999%) and Tm2O3 (99.98%) were purchased from Beijing Lansu Co. China. FeCl3·6H2O, trisodium citrate, sodium acetate (NaAc), ethylene glycol, tetraethyl orthosilicate (TEOS), urea, ammonia solution (28 wt%), NaF, HF (40%), absolute ethanol and hydrochloric solution were purchased from Sinopharm Chemical Reagent Co., China. Rare earth chlorides (LnCl3, Ln: Lu, Yb, Er, Tm) were prepared by dissolving the corresponding metal oxide in 10%

Synthesis and characterization of MUCNP

A step-wise method has been developed to synthesize the multifunctional Fe3O4@NaLuF4:Yb,Er/Tm nanostructure (abbreviated as MUCNP). The details of the procedure are summarized in Scheme 1. Firstly, uniform Fe3O4 cores with diameter of ∼180 nm were prepared by a modified polyol method following a procedure described previously [43]. The particles show good dispersibility in polar solvents (such as water and ethanol) due to the capping of citrate groups on the surface. Silica coating was then

Conclusions

A Fe3O4@NaLuF4:Yb,Er/Tm nanophophor (MUCNP) has been developed using a step-wise method. It combines upconversion luminescent, magnetic and X-ray attenuation properties. The T2 magnetic resonance properties result from the Fe3O4 cores, while the NaLuF4:Yb,Er/Tm outer shell shows excellent UCL emission and enhances positive contrast in CT images. The multifunctional MUCNP has been used as an MR, CT and UCL probe for multimodal imaging of mice bearing tumors. In vitro UCL imaging study confirms

Conflict of interest

No financial conflict of interest was reported by the authors of this paper.

Acknowledgments

The authors thank Yonghui Deng, Wei Li, from Department of Chemistry, Fudan University, for thoughful discussions. This work was financially supported by NSFC (20825101), SSTC (1052nm03400 and 11XD1400200), the State Key Basic Research Program of China (2011AA03A407 and 2012CB932403), IRT0911, SLADP (B108) and the CAS/SAFEA International Partnership Program for Creative Research Teams.

References (49)

  • A. Xia et al.

    Core-shell NaYF4:Yb3+, Tm3+@FexOy nanocrystals for dual-modality T2-enhanced magnetic resonance and NIR-to-NIR upconversion luminescent imaging of small-animal lymphatic node

    Biomaterials

    (2011)
  • N. Kawahashi et al.

    Preparation of hollow spherical particles of yttrium compounds

    J Colloid Interface Sci

    (1991)
  • N. Kawahashi et al.

    Preparation and properties of uniform coated colloidal particles: V. yttrium basic carbonate on polystyrene latex

    J Colloid Interf Sci

    (1990)
  • F. Wang et al.

    Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals

    Chem Soc Rev

    (2009)
  • D.K. Chatterjee et al.

    Small upconverting fluorescent nanoparticles for biomedical applications

    Small

    (2010)
  • J. Zhou et al.

    Upconversion nanophosphors for small-animal imaging

    Chem Soc Rev

    (2012)
  • J. Shen et al.

    Luminescent rare earth nanomaterials for bioprobe applications

    Dalton Trans

    (2008)
  • C.X. Li et al.

    Rare earth fluoride nano-/microcrystals: synthesis, surface modification and application

    J Mater Chem

    (2010)
  • F. Wang et al.

    Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping

    Nature

    (2010)
  • F. Wang et al.

    Tuning upconversion through energy migration in core–shell nanoparticles

    Nat Mater

    (2011)
  • Z.G. Chen et al.

    Versatile synthesis strategy for carboxylic acid-functionalized upconverting nanophosphors as biological labels

    J Am Chem Soc

    (2008)
  • H. Hu et al.

    Facile epoxidation strategy for producing amphiphilic up-converting rare-earth nanophosphors as biological labels

    Chem Mater

    (2008)
  • M.X. Yu et al.

    Laser scanning up-conversion luminescence microscopy for imaging cells labeled with rare-earth nanophosphors

    Anal Chem

    (2009)
  • L.Q. Xiong et al.

    High contrast upconversion luminescence targeted imaging in vivo using peptide-labeled nanophosphors

    Anal Chem

    (2009)
  • Cited by (271)

    • Modulation of proteins by rare earth elements as a biotechnological tool

      2024, International Journal of Biological Macromolecules
    • Nanomaterials in bioimaging and cell labeling

      2023, Applications of Multifunctional Nanomaterials
    • Metallic nanoparticles for theranostic application

      2023, Inorganic Nanosystems: Theranostic Nanosystems, Volume 2
    View all citing articles on Scopus
    1

    Fax: +86 21 55664185.

    View full text